Phosphodiesterase 4 in osteoblastic osteosarcoma cells as a potential target for growth inhibition
作者:
Motoshi Narita,
Taku Murata,
Kasumi Shimizu,
Takeo Sugiyama,
Toshiyuki Nakagawa,
Vincent Manganiello,
Toshiro Tagawa,
期刊:
Anti-Cancer Drugs
(OVID Available online 2003)
卷期:
Volume 14,
issue 5
页码: 377-381
ISSN:0959-4973
年代: 2003
出版商: OVID
关键词: osteoblastic osteosarcoma;phosphodiesterase
数据来源: OVID
摘要:
Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed that HOSM-1 cells, an osteosarcoma cell line established from human mandible, expressed mRNA for osteoblastic markers, such as alkaline phosphatase, osteonectin, osteocalcin and parathyroid hormone receptor, thus exhibiting an osteoblastic phenotype. We have investigated a possible role of cyclic nucleotide phosphodiesterases (PDEs) in osteosarcoma cells. RT-PCR analysis revealed that HOSM-1 cells expressed mRNA for PDE4A, 4B and 4C. In addition, rolipram, a specific inhibitor of PDE4, inhibited HOSM-1 cell proliferation. The finding that PDE4 is involved in proliferation of osteosarcoma cells suggests the possibility that PDE4 may be a new target for antitumor therapy.
点击下载:
PDF
(152KB)
返 回